AI English summary of an SEC filing — figures as filed

UnitedHealth Group said on Tuesday, March 28, 2024, that John Rex, its Chief Financial Officer, has been appointed President effective April 1, 2024, while he continues as CFO.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Mar 28, 2024Period of report Mar 28, 2024Summary published (UTC) Oct 30, 2026

Key points

AI summary

UnitedHealth Group said on Tuesday, March 28, 2024, that John Rex, its Chief Financial Officer, has been appointed President effective April 1, 2024, while he continues as CFO.
Rex will continue in his existing role as Chief Financial Officer while also serving as President, the company said.
UnitedHealth said Mr. Rex's business experience and other information required by Item 5.02 can be found in the company's 2023 10-K and 2023 Proxy Statement.
The company filed this 8-K under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and listed March 28, 2024 as the date of the earliest event reported.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

John Rex to become President in addition to CFO role from April 1

UnitedHealth Group said on Tuesday, March 28, 2024, that John Rex, its Chief Financial Officer, has been appointed President effective April 1, 2024, while he continues as CFO.

Source · Based on the filing body and exhibits

Rex to keep existing CFO duties

Rex will continue in his existing role as Chief Financial Officer while also serving as President, the company said.

Source · Based on the filing body and exhibits

Career details in 2023 10-K and Proxy Statement

UnitedHealth said Mr. Rex's business experience and other information required by Item 5.02 can be found in the company's 2023 10-K and 2023 Proxy Statement.

Source · Based on the filing body and exhibits

Item 5.02 officer change disclosure

The company filed this 8-K under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and listed March 28, 2024 as the date of the earliest event reported.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.